TR200002973T2 - Isı şoku proteinlerini kullanarak enflamatuar hastalıkların tedavi edilmesi - Google Patents
Isı şoku proteinlerini kullanarak enflamatuar hastalıkların tedavi edilmesiInfo
- Publication number
- TR200002973T2 TR200002973T2 TR2000/02973T TR200002973T TR200002973T2 TR 200002973 T2 TR200002973 T2 TR 200002973T2 TR 2000/02973 T TR2000/02973 T TR 2000/02973T TR 200002973 T TR200002973 T TR 200002973T TR 200002973 T2 TR200002973 T2 TR 200002973T2
- Authority
- TR
- Turkey
- Prior art keywords
- inflammatory diseases
- heat shock
- treating inflammatory
- shock proteins
- mammal
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 102000002812 Heat-Shock Proteins Human genes 0.000 title 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 206010014950 Eosinophilia Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000028709 inflammatory response Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000004043 responsiveness Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Ophthalmology & Optometry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1233098A | 1998-01-23 | 1998-01-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200002973T2 true TR200002973T2 (tr) | 2001-02-21 |
Family
ID=21754459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/02973T TR200002973T2 (tr) | 1998-01-23 | 1999-01-22 | Isı şoku proteinlerini kullanarak enflamatuar hastalıkların tedavi edilmesi |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20020006410A1 (enExample) |
| EP (1) | EP1049483A1 (enExample) |
| JP (1) | JP2002509074A (enExample) |
| KR (1) | KR20010040389A (enExample) |
| CN (1) | CN1324243A (enExample) |
| AU (1) | AU2337499A (enExample) |
| BR (1) | BR9907228A (enExample) |
| CA (1) | CA2318263A1 (enExample) |
| CZ (1) | CZ20002669A3 (enExample) |
| HU (1) | HUP0100241A2 (enExample) |
| IL (1) | IL137404A0 (enExample) |
| NO (1) | NO20003775L (enExample) |
| PL (1) | PL342166A1 (enExample) |
| TR (1) | TR200002973T2 (enExample) |
| WO (1) | WO1999037319A1 (enExample) |
| ZA (1) | ZA99499B (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7992572B2 (en) * | 1998-06-10 | 2011-08-09 | Asthmatx, Inc. | Methods of evaluating individuals having reversible obstructive pulmonary disease |
| AU3239400A (en) * | 1999-02-22 | 2000-09-04 | University Of Iowa Research Foundation, The | Method for inhibiting inflammatory responses |
| WO2001022816A1 (en) * | 1999-09-30 | 2001-04-05 | National Jewish Medical And Research Center | MODULATION OF ηδ T CELLS TO REGULATE AIRWAY HYPERRESPONSIVENESS |
| US6737398B1 (en) | 1999-09-30 | 2004-05-18 | National Jewish Medical And Research Center | Modulation of γδ T cells to regulate airway hyperresponsiveness |
| US7235649B2 (en) * | 2000-03-24 | 2007-06-26 | Duke University | Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same |
| GB0028122D0 (en) * | 2000-11-17 | 2001-01-03 | St Georges Entpr Ltd | Method |
| AUPR381601A0 (en) * | 2001-03-19 | 2001-04-12 | Monash University | Method of treating respiratory conditions |
| AU2002327804B2 (en) * | 2001-10-01 | 2008-09-11 | Duke University | Three dimensional structure of crystalline GRP94 binding domain, and its methods of use |
| JP4632664B2 (ja) * | 2002-02-13 | 2011-02-16 | デューク ユニバーシティ | 非ペプチド結合ストレス応答性ポリペプチドによる免疫応答の調節 |
| US20100111927A1 (en) * | 2002-08-23 | 2010-05-06 | Sunyoung Kim | Compositions Comprising Actinidia and Methods of Use Thereof |
| KR100615389B1 (ko) * | 2002-08-23 | 2006-08-25 | (주)헬릭서 | 다래 추출물을 함유하는 알러지성 질환 및 비알러지성염증 질환의 예방 및 개선용 건강 기능 식품 |
| GB0226105D0 (en) * | 2002-11-08 | 2002-12-18 | St Georges S Entpr Ltd | Pain relief agents |
| CA2626692A1 (en) * | 2005-10-20 | 2007-04-26 | Cbio Limited | Treatment of hypersensitivity |
| KR100768265B1 (ko) * | 2005-11-10 | 2007-10-17 | 한국화학연구원 | 혈액내 순환시간을 향상시키기 위한 헤파린이 수식된리포솜 및 이의 제조방법 |
| ES2385735T3 (es) | 2008-06-26 | 2012-07-31 | Orphazyme Aps | Uso de Hsp70 como regulador de la actividad enzimática |
| WO2010086418A1 (en) * | 2009-01-29 | 2010-08-05 | Alfa Biogene International B.V. | Functional food product comprising heat shock protein or a hydrolysate thereof |
| EP2397074B1 (en) * | 2010-06-19 | 2012-10-24 | M Stenqvist AB | A system and computer readable medium for determination of transpulmonary pressure in a patient connected to a breathing apparatus |
| RU2013125923A (ru) | 2010-11-30 | 2015-01-10 | Орфазиме Апс | СПОСОБЫ УВЕЛИЧЕНИЯ ВНУТРИКЛЕТОЧНОЙ АКТИВНОСТИ Hsp70 |
| WO2012097255A2 (en) * | 2011-01-14 | 2012-07-19 | Scott & White Healthcare | Therapeutic effect of heat shock proteins in preventing amylin aggregation in type 2 diabetes mellitus |
| WO2012154967A1 (en) | 2011-05-12 | 2012-11-15 | Proteostasis Therapeutics, Inc. | Proteostasis regulators |
| WO2012174549A2 (en) * | 2011-06-16 | 2012-12-20 | Children's Hospital Medical Center | Blockade of eosinophil production by toll-like receptors |
| US10034915B2 (en) | 2011-06-23 | 2018-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Small heat shock proteins and active fragments thereof as a therapy for inflammation and ischemia |
| EP2806875B1 (en) | 2012-01-25 | 2017-07-19 | Proteostasis Therapeutics, Inc. | Proteasome activity modulating compounds |
| DK3193840T3 (da) | 2014-09-15 | 2021-08-16 | Orphazyme As | Arimoclomol-formulering |
| EP3402572B1 (en) | 2016-01-13 | 2022-03-16 | Children's Hospital Medical Center | Compositions and methods for treating allergic inflammatory conditions |
| US10898476B2 (en) | 2016-04-13 | 2021-01-26 | Orphazyme A/S | Heat shock proteins and cholesterol homeostasis |
| DK3782624T3 (da) | 2016-04-29 | 2025-12-15 | Zevra Denmark As | Arimoclomol til behandling af glucocerebrosidase-associerede lidelser |
| CN106243203B (zh) * | 2016-08-04 | 2019-12-10 | 上海市农业科学院 | 一种草菇热激蛋白VvHSP70及其应用 |
| CN106220718B (zh) * | 2016-08-04 | 2019-12-10 | 上海市农业科学院 | 一种草菇热激蛋白VvHSP60及其应用 |
| US11859250B1 (en) | 2018-02-23 | 2024-01-02 | Children's Hospital Medical Center | Methods for treating eosinophilic esophagitis |
| EP3781588B1 (en) | 2018-04-20 | 2024-10-30 | Children's Hospital Medical Center | Blood biomarker for eosinophilic gastrointestinal disorders |
| CR20200652A (es) | 2018-06-27 | 2021-04-28 | Proteostasis Therapeutics Inc | Compuestos que aumentan la actividad del proteosoma |
| JP7551087B2 (ja) | 2018-06-27 | 2024-09-17 | キネタ， インコーポレイテッド | プロテアソーム活性増強化合物 |
| US12297501B2 (en) | 2019-02-25 | 2025-05-13 | Children's Hospital Medical Center | Methods for diagnosing and treating eosinophilic gastritis |
| EP4247792A1 (en) | 2020-11-19 | 2023-09-27 | Zevra Denmark A/S | Processes for preparing arimoclomol citrate and intermediates thereof |
| CN114046596B (zh) * | 2021-11-17 | 2022-09-23 | 重庆大学 | 基于trp生化指标检测的室内空气质量控制系统及方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5348945A (en) * | 1990-04-06 | 1994-09-20 | Wake Forest University | Method of treatment with hsp70 |
| ATE154759T1 (de) * | 1990-11-08 | 1997-07-15 | Univ London | Mycobacterium als adjuvans für antigene |
| GB9211736D0 (en) * | 1992-06-03 | 1992-07-15 | Univ Cardiff | Allergic treatment |
| AU736318B2 (en) * | 1996-11-26 | 2001-07-26 | Nventa Biopharmaceuticals Corporation | Immune responses using compositions containing stress proteins |
-
1999
- 1999-01-22 JP JP2000528300A patent/JP2002509074A/ja active Pending
- 1999-01-22 HU HU0100241A patent/HUP0100241A2/hu unknown
- 1999-01-22 PL PL99342166A patent/PL342166A1/xx not_active Application Discontinuation
- 1999-01-22 CN CN99804346A patent/CN1324243A/zh active Pending
- 1999-01-22 AU AU23374/99A patent/AU2337499A/en not_active Abandoned
- 1999-01-22 BR BR9907228-9A patent/BR9907228A/pt not_active IP Right Cessation
- 1999-01-22 WO PCT/US1999/001421 patent/WO1999037319A1/en not_active Ceased
- 1999-01-22 TR TR2000/02973T patent/TR200002973T2/xx unknown
- 1999-01-22 CZ CZ20002669A patent/CZ20002669A3/cs unknown
- 1999-01-22 IL IL13740499A patent/IL137404A0/xx unknown
- 1999-01-22 EP EP99903321A patent/EP1049483A1/en not_active Withdrawn
- 1999-01-22 ZA ZA9900499A patent/ZA99499B/xx unknown
- 1999-01-22 KR KR1020007008033A patent/KR20010040389A/ko not_active Withdrawn
- 1999-01-22 CA CA002318263A patent/CA2318263A1/en not_active Abandoned
-
2000
- 2000-07-21 NO NO20003775A patent/NO20003775L/no not_active Application Discontinuation
-
2001
- 2001-08-17 US US09/932,483 patent/US20020006410A1/en not_active Abandoned
-
2006
- 2006-09-25 US US11/534,782 patent/US20070179087A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO20003775L (no) | 2000-09-22 |
| EP1049483A1 (en) | 2000-11-08 |
| JP2002509074A (ja) | 2002-03-26 |
| PL342166A1 (en) | 2001-05-21 |
| US20070179087A1 (en) | 2007-08-02 |
| ZA99499B (en) | 1999-07-22 |
| CN1324243A (zh) | 2001-11-28 |
| WO1999037319A1 (en) | 1999-07-29 |
| NO20003775D0 (no) | 2000-07-21 |
| KR20010040389A (ko) | 2001-05-15 |
| CA2318263A1 (en) | 1999-07-29 |
| AU2337499A (en) | 1999-08-09 |
| BR9907228A (pt) | 2000-10-24 |
| IL137404A0 (en) | 2001-07-24 |
| HUP0100241A2 (hu) | 2001-06-28 |
| US20020006410A1 (en) | 2002-01-17 |
| CZ20002669A3 (cs) | 2001-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200002973T2 (tr) | Isı şoku proteinlerini kullanarak enflamatuar hastalıkların tedavi edilmesi | |
| FI963218A0 (fi) | Mykofenolihapon 5-substituoidut johdannaiset | |
| FR12C0004I2 (fr) | Anticorps contre l'antigene ctla-4 humain et utilisation | |
| CY1119742T1 (el) | Βιολογικα συστηματα μεταφορας πολλαπλου-συστατικου | |
| DE60044058D1 (de) | Mit entzündlichen darmerkrankungen (ibd) assoziierte mikrobielle antigene und verfahren derer anwendung | |
| CY1118443T1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| ATE405647T1 (de) | Rekombinantes gelatin in impstoffen | |
| ATE211467T1 (de) | 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung | |
| TR200002284T2 (tr) | Mage ailesinden tümör ile ilgili tümör türevleri | |
| NO20001240D0 (no) | Kay-A immunsystemprotein | |
| DE60136169D1 (de) | Immunregulierer | |
| ATE232396T1 (de) | Oxydiertes thymosin beta 4 | |
| DK0876398T3 (da) | Induktion af immunrespons med ønskede determinanter | |
| NO970631D0 (no) | Fremgangsmåter for behandling av sepsis eller betennelsessykdommer med oxypurin-nukleosider | |
| DE60109430D1 (de) | An entzündlichen darmerkrankungen beteiligte gene und deren verwendung | |
| TR200001948T2 (tr) | Mikobakteri vaccaesinden türetilen kompozisyonlar ve bunların kullanımları için metotlar. | |
| DK1082131T3 (da) | Immunoregulator | |
| FI881413A7 (fi) | Menetelmä 3'-atsido-3'-deoksitymidiinin valmistamiseksi. | |
| DE69802131D1 (de) | Humane Protein-Kinase hYAK3 | |
| ITMI942238A0 (it) | Anticorpi naturali contro proteine allogeniche e xenogeniche e me- todi per la loro determinazione | |
| NO20011412D0 (no) | FremgangsmÕter for nedmodulering av immunresponsen til terapeutiske proteiner | |
| EP1071325A4 (en) | COMPOSITIONS AND METHODS FOR ANTI-SPECIFIC Vaccination | |
| EP1257298A4 (en) | KOSMID-DNA CONSTRUCTS AND METHOD FOR THE PRODUCTION AND USE THEREOF | |
| DE69932711D1 (de) | Proteine mit modulatorischer aktivität gegenüber dem immunsystem und behandlungen für immunologische erkrankungen | |
| DE69836226D1 (de) | Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone |